LBA2 – JUPITER-02: Randomized, double-blind, phase III study of toripalimab or placebo plus gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (NPC) Abstract Slides Abstract Authors: Rui-hua Xu, Hai-Qiang Mai, Qiu-Yan Chen, Dongping Chen, Chaosu Hu, Kunyu Yang, Jiyu Wen, Jin-Gao Li, Yingrui Shi, Feng Jin, Ruilian Xu, Jianji Pan, Shenhong…
OC 60.2 – Emicizumab Treatment is Efficacious and Well Tolerated Long Term in Persons with Haemophilia A (PwHA) with or without FVIII Inhibitors: Pooled Data from Four HAVEN Studies Presentation Oral Communication Session Meeting: ISTH 2019 Congress Presenter: M. Callaghan Presentation Date: July 9, 2019 Abstract #: OC 60.2 / 358 Disclaimer This content was…
Inclusief de drie belangrijkste trends voor de komende 3 tot 5 jaar In dit boek staat informatie over zorg op afstand, vooral digitale zorg. Maar wat is digitale zorg precies? Hoever zijn de ontwikkelingen op dat gebied? Wat is nodig voor een goede implementatie van digitale zorg? Hoe is de bekostiging geregeld? En hoe zit…
JUPITER-02: Randomized, double-blind, phase III study of toripalimab or placebo plus gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (NPC) Video Abstract Slides Video Abstract Authors: Rui-hua Xu, Hai-Qiang Mai, Qiu-Yan Chen, Dongping Chen, Chaosu Hu, Kunyu Yang, Jiyu Wen, Jin-Gao Li, Yingrui Shi, Feng Jin, Ruilian Xu, Jianji Pan, Shenhong…
Caplacizumab prevents refractoriness and mortality in acquired thrombotic thrombocytopenic purpura: integrated analysis Payvandi et al. Blood Advances; 2021, 5(8): 2137-2141 Select your desired language: English German | Deutsch Spanish | Español Italian | Italiano English Access ePrint German | Deutsch Access ePrint English version without login Spanish | Español Coming soon Italian | Italiano…
OlympiA: A phase III, multicenter, randomized, placebo-controlled trial of adjuvant olaparib after (neo)adjuvant chemotherapy in patients with germline BRCA1/2 mutations and high-risk HER2-negative early breast cancer Video Abstract Slides Video Abstract Authors: Andrew Tutt, Judy Ellen Garber, Bella Kaufman, Giuseppe Viale, Debora Fumagalli, Priya Rastogi, Richard D. Gelber, Evandro de Azambuja, Anitra Fielding, Judith Balmana…
CheckMate 067: 6.5-year outcomes in patients (pts) with advanced melanoma Video Abstract Slides Video Abstract Authors: Jedd D. Wolchok, Vanna Chiarion-Sileni, Rene Gonzalez, Jean-Jacques Grob, Piotr Rutkowski, Christopher D. Lao, Charles Lance Cowey, Dirk Schadendorf, John Wagstaff, Reinhard Dummer, Pier Francesco Ferrucci, Michael Smylie, Marcus O. Butler, Andrew Graham Hill, Ivan Marquez-Rodas, John B. A.…
Welke behandelingen zijn er en wat past bij u? Bij u is acute myeloïde leukemie (AML) vastgesteld. Dat kan betekenen dat er veel op u en uw naasten afkomt. Uw arts geeft u zoveel mogelijk informatie over wat u kunt verwachten. Deze brochure geeft een overzicht van die informatie: wat is AML, welke behandelingen zijn er…
Comparative Efficacy of Cabozantinib and Regorafenib for Advanced Hepatocellular Carcinoma Video Abstract https://vimeo.com/528564038 ePrint Author(s): Robin K. Kelley et al. Published: May 18, 2020 Copyright: The Author(s) 2020. By accessing this ePrint you agree to our terms and conditions (click to view) By accessing this content you are agreeing to the following terms and conditions,…
A regimen with caplacizumab, immunosuppression and plasma exchange prevents unfavorable outcomes in immune-mediated TTP Coppo et al. Blood 2021; 137(6): 733–742. Select your desired language: English German | Deutsch Spanish | Español French | Français Italian | Italiano Japanese | 日本語 English Access ePrint German | Deutsch English version without login Access ePrint Spanish |…